Cowen Starts Neuroderm Ltd (NDRM) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/23/2026
- Wall Street indexes dip with technology earnings, rising oil in focus
- Google increases capex forecast again after cloud-driven quarterly beat
- As Musk pivots beyond cars, Tesla’s autos engine is under strain
- Oil settles up more than 3% to six-week high as Mideast conflict threatens oil transit routes
- Can Alphabet earnings reignite investor enthusiasm for the Magnificent Seven?
Roth Capital Starts Neuroderm Ltd (NDRM) at Buy
December 9, 2014 7:08 AM ESTRoth Capital initiated coverage on Neuroderm Ltd (NASDAQ: NDRM) with a Buy rating and a price target of $17.50.
For an analyst ratings summary and ratings history on Neuroderm Ltd click here. For more ratings news on Neuroderm Ltd click here.
Shares of Neuroderm Ltd closed at $8.04 yesterday.
... MoreJefferies Starts Neuroderm Ltd (NDRM) at Buy, $17 PT
December 9, 2014 6:49 AM ESTJefferies initiates coverage on Neuroderm Ltd (NASDAQ: NDRM) with a Buy rating and a price target of $17.00.
Analyst Thomas Wei said, "We view NDRM's Parkinsons disease (PD) assets, ND0612L and ND0612H, as two relatively de-risked drugs among mid-stage biotech... More
